Our team of experts will work with you to create a plan that fits your lifestyle and preferences
Use of GLP-1RAs and SGLT2is is influenced by cost, insurance coverage, access to care, and structural barriers, with lower use observed among socioeconomically disadvantaged individuals and racial and ethnic minority groups [56, 59, 60]
Early preclinical studies in experimental diabetes demonstrated toxicities such as anemia, thrombocytopenia, splenomegaly, lymphadenopathy, lung histiocytosis, mortality with multiple organ pathology, gastrointestinal, and central nervous system toxicity
doi:10.55894/dv3.11
Medicaid does not cover this class of weight loss drugs, and even private insurance offers limited coverage of the drugs for weight loss